Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 1692234 Seattle, WA
Back to RYTM Full portfolio

Position in RYTM

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$9,627,297
-$436,172 QoQ
Shares Held
86,709
-25.1% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
12 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in RYTM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,846 across 308 Biotechnology names. RYTM ranks #40 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 336,990 $167,393,033
2 REGN
Regeneron Pharmaceuticals, Inc.
 230,151 $143,508,345
3 RPRX
Royalty Pharma plc
 1,694,250 $94,996,587
4 INCY
Incyte Corp
 425,616 $48,247,822
5 ALNY
Alnylam Pharmaceuticals, Inc.
 158,228 $47,631,369
6 BMRN
Biomarin Pharmaceutical Inc
 783,148 $44,811,725
7 LGND
Ligand Pharmaceuticals Inc
 120,304 $38,026,888
8 PTCT
Ptc Therapeutics, Inc.
 418,025 $34,098,295

All Filings in RYTM

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,627,297 86,709
2026-03-31 $10,063,469 115,712
2025-12-31 $14,362,624 134,180
2025-09-30 $15,923,898 157,678
2025-06-30 $8,277,761 130,998
2025-03-31 $6,079,788 114,778
2024-12-31 $55,811 997
2024-09-30 $52,075 994
2024-06-30 $82,530 2,010
2024-03-31 $16,682 385
2023-06-30 $18,139 1,100
2020-09-30 $127,657 5,891